Cargando…

Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma

Urothelial carcinomas account for the majority of all primary bladder cancers, making bladder cancer the second most frequent genitourinary malignancy after prostate cancer. Bladder cancer risk rises with age and most of them return after resection due to their multifocal distribution, and they ofte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponnaboina, Divya Madhuri, Perumandal, Sushmitha, I, Sreelakshmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204779/ https://www.ncbi.nlm.nih.gov/pubmed/37228532 http://dx.doi.org/10.7759/cureus.38018

Ejemplares similares

DOG-1 as a Myoepithelial Marker in Discriminating Invasive Breast Carcinomas From Non-Invasive Breast Lesions
por: Perumandal, Sushmitha, et al.
Publicado: (2023)

Overexpression of Her-2 in Biopsy-Proven Urothelial Carcinoma Patients From Pakistan
por: Chughtai, Anila, et al.
Publicado: (2022)

Androgen Receptor: Evaluation and Correlation with Recurrence and Clinicopathological Parameters in Papillary Urothelial Carcinomas of the Urinary Bladder
por: Mumtaz, Shazia, et al.
Publicado: (2020)

Quantitative Analysis of Tumor-Associated Mast Cells in Recurrent and Non-recurrent Urothelial Bladder Cancer in Stage pTa and pT1
por: Popov, Hristo, et al.
Publicado: (2021)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Role of GATA3 in Early-Stage Urothelial Bladder Carcinoma Local Recurrence
por: Popov, Hristo, et al.
Publicado: (2023)

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb
por: Hitchings, A W, et al.
Publicado: (2004)

Expression of p53 and p16 in Carcinoma Breast Tissue: Depicts Prognostic Significance or Coincidence
por: Rana, Manjit K, et al.
Publicado: (2021)

Study of the Immunohistochemical Expression of p63 in Benign Lesions and Carcinoma of the Breast at a Tertiary Hospital in South India
por: Prabhu, Shreya Dinesh, et al.
Publicado: (2023)

Fibroblast Growth Factor-2 and the Invasive Potential in Urothelial Malignancies of the Bladder
por: Popov, Hristo, et al.
Publicado: (2023)

Aberrant Expression of p63 in an Adenocarcinoma of the Prostate That Has Metastasized to the Oral Cavity
por: Khalid, Rafiq, et al.
Publicado: (2022)

Sarcomatoid Urothelial Carcinoma of the Urinary Bladder With Chondrosarcomatous and Concurrent Divergent Squamous Cell Carcinoma Differentiation– A Rare Entity
por: Kumar Pal, Atanu, et al.
Publicado: (2022)

Solitary Calvarial Metastasis As the First Presentation of Urothelial Bladder Cancer
por: Bistazzoni, Simona, et al.
Publicado: (2021)

Urothelial Papilloma of the Urinary Bladder: A Case Report and Literature Review of a Rare Entity
por: Abdel Gawad, Ahmed M, et al.
Publicado: (2022)

Review of the Role of HER2/neu in Colorectal Carcinomas
por: Achalla, Lakshmi Sai Vijay, et al.
Publicado: (2022)

The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette–Guerin
por: Hegazy, Raafat, et al.
Publicado: (2015)

Metastatic Plasmacytoid Urothelial Carcinoma Masquerading as a Primary Signet Ring Cell Carcinoma of the Duodenum
por: Mir, Adil S, et al.
Publicado: (2023)

Mutant Phenotype p53 Immunohistochemical Expression Is Associated With Poor Prognostic Parameters and Disease-Free Survival in Triple-Negative Metaplastic Breast Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2021)

Sarcomatoid Urothelial Carcinoma With Myxoid Stroma: A Case Report and Diagnostic Approach
por: Taseer, Rabia, et al.
Publicado: (2021)

A population-based study of immunohistochemical detection of p53 alteration in bladder cancer
por: Kelsey, K T, et al.
Publicado: (2004)

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder
por: Latif, Z, et al.
Publicado: (2003)

Immunohistochemical analysis of beta-catenin, E-cadherin and p53 in canine gastrointestinal epithelial tumors
por: SAITO, Tsubasa, et al.
Publicado: (2020)

The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma
por: Borowczak, Jędrzej, et al.
Publicado: (2022)

Differentiation of Urothelial Carcinoma into Two Distinct Subtypes, Glandular and Squamous, in Three Different Organs
por: El-Asmar, Jose M, et al.
Publicado: (2020)

Tumour Behaviour of Low-Grade Papillary Urothelial Carcinoma: A Single-Centre Retrospective Study
por: Dutta, Satya, et al.
Publicado: (2021)

Primary Small Cell Carcinoma of the Bladder
por: Kassas, Juliette M, et al.
Publicado: (2021)

Impaired ΔNp63 expression associates with reduced β-catenin and aggressive phenotypes of urothelial neoplasms
por: Koga, F, et al.
Publicado: (2003)

Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours
por: Yoshida, T, et al.
Publicado: (2004)

Cytological Changes and Immunocytochemistry Expression of P53 in Oral Mucosa Among Waterpipe Users in the Kingdom of Saudi Arabia
por: Elmahdi, Faris M, et al.
Publicado: (2022)

Renal Oncocytoma and Pelvic Urothelial Carcinoma in a Nephrectomy Specimen of a 72-Year-Old Patient
por: Atique, Usman, et al.
Publicado: (2023)

Relationship of Tubule Formation, Indian File Pattern and Apocrine Change With Estrogen and Progesterone Receptors and HER2 Immunostaining
por: Singh, Divya, et al.
Publicado: (2022)

p53, p63 and p73 in the wonderland of S. cerevisiae
por: Billant, Olivier, et al.
Publicado: (2017)

Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma
por: Rosenthal, A N, et al.
Publicado: (2003)

P63 and P73 Activation in Cancers with p53 Mutation
por: Cai, Bi-He, et al.
Publicado: (2022)

Nephrogenic Adenoma of the Prostatic Urethra Mimicking Prostatic and Bladder Carcinomas
por: Beeter, Maria C, et al.
Publicado: (2023)

p63 and p53: Collaborative Partners or Dueling Rivals?
por: Woodstock, Dana L., et al.
Publicado: (2021)

Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Carcinoma: A Potential Area of Focus for Future Diagnostics
por: Kaur, Simrandeep, et al.
Publicado: (2022)

Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma
por: Srinivasan, Malini, et al.
Publicado: (2011)

Impact of the Ki-67 labeling index and p53 expression status on disease-free survival in pT1 urothelial carcinoma of the bladder
por: Vetterlein, Malte W., et al.
Publicado: (2017)

Role of Cytokeratin 20 as a Predictive and Prognostic Marker in Urothelial Neoplasms
por: Popov, Hristo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u05le6q1uhic6ggeotrvkjgn4a